Ramsay David A's Form 4 filing
Halozyme Therapeutics, Inc. (HALO) · filed Jul 2, 2026
- Accession no.
- 0001159036-26-000096
- Filed
- Jul 2, 2026, 4:45 PM ET
- Trade date
- Jun 30-Jul 1, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ramsay David ACIK 0001283292 | Officer (EVP, PRESIDENT, DRUG DELIVERY) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | MOption exerciseAcquired | +10,000 | $0.00 | $0 | 10,000 | Direct | |
| Jun 30, 2026 | Common Stock | FTax withholdingDisposed | −5,408 | $78.27 | −$423,284.16 | 4,592 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct | |
| Jul 1, 2026 | Common Stock | AGrant or awardAcquired | +16,232 | $0.00 | $0 | 16,232 | Direct | |
| Jul 1, 2026 | Common Stock | AGrant or awardAcquired | +39,823 | $0.00 | $0 | 39,823 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.